Originally developed to treat diabetes, a class of drugs known as glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are ...
Amneal and BioCorRx have earned the ire of the FDA’s Office of Prescription Drug Promotion (OPDP), with both being hit by ...
Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted ...
The FDA is seeking (PDF) new powers to hold companies accountable for misleading direct-to-consumer (DTC) ads, adding legislat | The FDA is seeking new powers to hold companies accountable for ...
The Trump administration dropped its fiscal 2027 budget request Friday, and the massive document release includes some ...
Detailed price information for Neurosense Therapeutics Ltd (NRSN-Q) from The Globe and Mail including charting and trades.
FDA grants orphan drug designation to rhenium (186Re) obisbemeda for pediatric glioma and ependymoma, supported by the phase ...
When a biopharma company known for its expertise in a specific domain turns to a collaborator to expand its capabilities in ...
Senju Pharma has launched a new drug for dry eye disease (DED) in Japan, Avarept, which is the first drug in the TRPV1 antagonist class to reach the market. Licensed from fellow Japanese drugmaker ...
Hong Kong’s Department of Health (DH) has begun a phased transition to the independent assessment of primary data on new ...
MedPage Today on MSN
Many Older Patients Can Ditch Common Thyroid Drug, Study Suggests
Experts call for better guidance on levothyroxine initiation, deprescribing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results